Bio-Rad Laboratories (BIO) Capital Expenditures Growth (5y) (2014 - 2026)
Powered by 
Analysis
Bio-Rad Laboratories (BIO) Capital Expenditures Growth (5y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.48 Bn | 221.41 Bn | 8.34 Bn |
| 2 | Danaher | 144.42 Bn | 140.08 Bn | 3.61 Bn |
| 3 | Agilent Technologies | 40.86 Bn | 39.11 Bn | 1.04 Bn |
| 4 | Illumina | 30.97 Bn | 29.80 Bn | 770.00 Mn |
| 5 | Revvity | 13.85 Bn | 12.83 Bn | 416.87 Mn |
| 6 | Bio-Techne | 11.27 Bn | 11.01 Bn | 211.39 Mn |
| 7 | Bio-Rad Laboratories | 10.11 Bn | 8.49 Bn | 345.80 Mn |
| 8 | Repligen | 9.33 Bn | 8.31 Bn | 110.04 Mn |
| 9 | 10x Genomics | 8.77 Bn | 8.21 Bn | 112.50 Mn |
| 10 | Bruker | 8.30 Bn | 8.09 Bn | 416.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.47% |
| Mar 31, 2026 | 8.95% |
| Dec 31, 2025 | -1.29% |
| Sep 30, 2025 | 9.67% |
| Jun 30, 2025 | 20.33% |
| Mar 31, 2025 | 9.76% |
| Dec 31, 2024 | 14.71% |
| Sep 30, 2024 | 5.27% |
| Jun 30, 2024 | 13.75% |
| Mar 31, 2024 | 11.21% |
| Dec 31, 2023 | -4.74% |
| Sep 30, 2023 | 14.85% |
| Jun 30, 2023 | 5.33% |
| Mar 31, 2023 | 5.62% |
| Dec 31, 2022 | 5.96% |
| Sep 30, 2022 | 18.72% |
| Jun 30, 2022 | 252.17% |
| Mar 31, 2022 | -14.77% |
| Dec 31, 2021 | 4.49% |
| Sep 30, 2021 | -2.58% |